Telo Genomics Corp. (TSXV:TELO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
0.00 (0.00%)
At close: Feb 27, 2026
Market Cap5.02M -48.2%
Revenue (ttm)n/a
Net Income-2.71M
EPS-0.03
Shares Out100.43M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,000
Average Volume86,712
Open0.0500
Previous Close0.0500
Day's Range0.0500 - 0.0500
52-Week Range0.0400 - 0.1300
Beta0.04
RSI51.44
Earnings DateFeb 25, 2026

About Telo Genomics

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company’s TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SM... [Read more]

Sector Healthcare
CEO Sabine Mai
Employees 6
Stock Exchange TSX Venture Exchange
Ticker Symbol TELO
Full Company Profile

Financial Performance

Financial Statements